NCT03612271View on ClinicalTrials.gov

mGlide RCT: A Clinical Glide Path To Close the Guideline-to-Practice Gap In HTN Management

NAActive, not recruitingINTERVENTIONAL

Enrollment

395

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

August 16, 2024

Study Completion Date

April 30, 2026

Conditions

Hypertension

Interventions

BEHAVIORAL

mGlide

BP will be automatically transmitted to the providers. The transmitted BP will be used for adjustment of anti-HTN medications as it occurs in clinical practice.

Trial Locations (1)

55415

Epidemiology Clinical Research Center, Minneapolis

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Minnesota

OTHER

NCT03612271 - mGlide RCT: A Clinical Glide Path To Close the Guideline-to-Practice Gap In HTN Management | Biotech Hunter | Biotech Hunter